Update on the safety profile of certolizumab pegol in rheumatoid arthritis: an integrated analysis from clinical trials

OBJECTIVE: To report the long-term safety data of certolizumab pegol (CZP) in rheumatoid arthritis (RA) accumulated as of 30 November 2011. DESIGN: Data from 10 completed randomised controlled trials (RCT) of CZP in RA and several open-label extensions (OLE) were pooled across all doses. Reported ad...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Ann Rheum Dis
Autors principals: Bykerk, V P, Cush, J, Winthrop, K, Calabrese, L, Lortholary, O, de Longueville, M, van Vollenhoven, R, Mariette, X
Format: Artigo
Idioma:Inglês
Publicat: BMJ Publishing Group 2015
Matèries:
Clinical and Epidemiological Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4283674/
https://ncbi.nlm.nih.gov/pubmed/24092417
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/annrheumdis-2013-203660
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars